Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives

Laura Marler, Martin Conda-Sheridan, Maris A. Cinelli, Andrew E. Morrell, Mark Cushman, Lian Chen, Ke Huang, Richard Van Breemen, John M. Pezzuto

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In the search for agents with cancer chemopreventive potential, 14-chloromethyl-12H-5,11adiazadibenzo[b,h]fiuoren-11-one (compound 1), originally synthesized as a potential topoisomerase I inhibitor, and 2,4-dibromo-1-hydroxyphenazine (compound 2), an analog of a substance found in the marine bacteria Streptomyces CNS284, were found to significantly enhance NADP(H):quinone oxidoreductase 1 (QR1), glutathione S-transferase (GST), and glutathione (GSH) levels in cell culture. However, following a short-term absorption study, analyses of livers from the treatment groups did not reveal a significant increase in QR1 or GST activity, or GSH levels. This was consistent with RT-PCR analyses of tissue samples. The compounds were absorbed, as judged by LCIMS analyses of serum and tissue samples, although levels were well below the concentrations required to mediate in vitro responses. Metabolites of compound 2 formed in vitro by human liver microzones were characterized using high resolution tandem mass spectrometry. In sum, the in vivo activity of these compounds appears to be diminished by low bioavailability, but this experimental approach indicates the importance of systematic biomarker investigation.

Original languageEnglish (US)
Pages (from-to)4873-4882
Number of pages10
JournalAnticancer Research
Volume30
Issue number12
StatePublished - Dec 1 2010

Fingerprint

Phenazines
Glutathione Transferase
Biological Products
Oxidoreductases
Topoisomerase I Inhibitors
Liver
Streptomyces
Tandem Mass Spectrometry
NADP
Biological Availability
Glutathione
Neoplasms
Cell Culture Techniques
Biomarkers
Bacteria
Polymerase Chain Reaction
Serum
In Vitro Techniques
benzoquinone

Keywords

  • Aromathecins
  • Cancer chemoprevention
  • Enzyme induction
  • Metabolism
  • Phenazines
  • RT-PCR

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Marler, L., Conda-Sheridan, M., Cinelli, M. A., Morrell, A. E., Cushman, M., Chen, L., ... Pezzuto, J. M. (2010). Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives. Anticancer Research, 30(12), 4873-4882.

Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives. / Marler, Laura; Conda-Sheridan, Martin; Cinelli, Maris A.; Morrell, Andrew E.; Cushman, Mark; Chen, Lian; Huang, Ke; Van Breemen, Richard; Pezzuto, John M.

In: Anticancer Research, Vol. 30, No. 12, 01.12.2010, p. 4873-4882.

Research output: Contribution to journalArticle

Marler, L, Conda-Sheridan, M, Cinelli, MA, Morrell, AE, Cushman, M, Chen, L, Huang, K, Van Breemen, R & Pezzuto, JM 2010, 'Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives', Anticancer Research, vol. 30, no. 12, pp. 4873-4882.
Marler L, Conda-Sheridan M, Cinelli MA, Morrell AE, Cushman M, Chen L et al. Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives. Anticancer Research. 2010 Dec 1;30(12):4873-4882.
Marler, Laura ; Conda-Sheridan, Martin ; Cinelli, Maris A. ; Morrell, Andrew E. ; Cushman, Mark ; Chen, Lian ; Huang, Ke ; Van Breemen, Richard ; Pezzuto, John M. / Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives. In: Anticancer Research. 2010 ; Vol. 30, No. 12. pp. 4873-4882.
@article{3e031c32ee59458f97c4643264e80da1,
title = "Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives",
abstract = "In the search for agents with cancer chemopreventive potential, 14-chloromethyl-12H-5,11adiazadibenzo[b,h]fiuoren-11-one (compound 1), originally synthesized as a potential topoisomerase I inhibitor, and 2,4-dibromo-1-hydroxyphenazine (compound 2), an analog of a substance found in the marine bacteria Streptomyces CNS284, were found to significantly enhance NADP(H):quinone oxidoreductase 1 (QR1), glutathione S-transferase (GST), and glutathione (GSH) levels in cell culture. However, following a short-term absorption study, analyses of livers from the treatment groups did not reveal a significant increase in QR1 or GST activity, or GSH levels. This was consistent with RT-PCR analyses of tissue samples. The compounds were absorbed, as judged by LCIMS analyses of serum and tissue samples, although levels were well below the concentrations required to mediate in vitro responses. Metabolites of compound 2 formed in vitro by human liver microzones were characterized using high resolution tandem mass spectrometry. In sum, the in vivo activity of these compounds appears to be diminished by low bioavailability, but this experimental approach indicates the importance of systematic biomarker investigation.",
keywords = "Aromathecins, Cancer chemoprevention, Enzyme induction, Metabolism, Phenazines, RT-PCR",
author = "Laura Marler and Martin Conda-Sheridan and Cinelli, {Maris A.} and Morrell, {Andrew E.} and Mark Cushman and Lian Chen and Ke Huang and {Van Breemen}, Richard and Pezzuto, {John M.}",
year = "2010",
month = "12",
day = "1",
language = "English (US)",
volume = "30",
pages = "4873--4882",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

TY - JOUR

T1 - Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives

AU - Marler, Laura

AU - Conda-Sheridan, Martin

AU - Cinelli, Maris A.

AU - Morrell, Andrew E.

AU - Cushman, Mark

AU - Chen, Lian

AU - Huang, Ke

AU - Van Breemen, Richard

AU - Pezzuto, John M.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - In the search for agents with cancer chemopreventive potential, 14-chloromethyl-12H-5,11adiazadibenzo[b,h]fiuoren-11-one (compound 1), originally synthesized as a potential topoisomerase I inhibitor, and 2,4-dibromo-1-hydroxyphenazine (compound 2), an analog of a substance found in the marine bacteria Streptomyces CNS284, were found to significantly enhance NADP(H):quinone oxidoreductase 1 (QR1), glutathione S-transferase (GST), and glutathione (GSH) levels in cell culture. However, following a short-term absorption study, analyses of livers from the treatment groups did not reveal a significant increase in QR1 or GST activity, or GSH levels. This was consistent with RT-PCR analyses of tissue samples. The compounds were absorbed, as judged by LCIMS analyses of serum and tissue samples, although levels were well below the concentrations required to mediate in vitro responses. Metabolites of compound 2 formed in vitro by human liver microzones were characterized using high resolution tandem mass spectrometry. In sum, the in vivo activity of these compounds appears to be diminished by low bioavailability, but this experimental approach indicates the importance of systematic biomarker investigation.

AB - In the search for agents with cancer chemopreventive potential, 14-chloromethyl-12H-5,11adiazadibenzo[b,h]fiuoren-11-one (compound 1), originally synthesized as a potential topoisomerase I inhibitor, and 2,4-dibromo-1-hydroxyphenazine (compound 2), an analog of a substance found in the marine bacteria Streptomyces CNS284, were found to significantly enhance NADP(H):quinone oxidoreductase 1 (QR1), glutathione S-transferase (GST), and glutathione (GSH) levels in cell culture. However, following a short-term absorption study, analyses of livers from the treatment groups did not reveal a significant increase in QR1 or GST activity, or GSH levels. This was consistent with RT-PCR analyses of tissue samples. The compounds were absorbed, as judged by LCIMS analyses of serum and tissue samples, although levels were well below the concentrations required to mediate in vitro responses. Metabolites of compound 2 formed in vitro by human liver microzones were characterized using high resolution tandem mass spectrometry. In sum, the in vivo activity of these compounds appears to be diminished by low bioavailability, but this experimental approach indicates the importance of systematic biomarker investigation.

KW - Aromathecins

KW - Cancer chemoprevention

KW - Enzyme induction

KW - Metabolism

KW - Phenazines

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=78751558932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751558932&partnerID=8YFLogxK

M3 - Article

C2 - 21187465

AN - SCOPUS:78751558932

VL - 30

SP - 4873

EP - 4882

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 12

ER -